EP1012260A4 - Interleukine-20 - Google Patents

Interleukine-20

Info

Publication number
EP1012260A4
EP1012260A4 EP98936854A EP98936854A EP1012260A4 EP 1012260 A4 EP1012260 A4 EP 1012260A4 EP 98936854 A EP98936854 A EP 98936854A EP 98936854 A EP98936854 A EP 98936854A EP 1012260 A4 EP1012260 A4 EP 1012260A4
Authority
EP
European Patent Office
Prior art keywords
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98936854A
Other languages
German (de)
English (en)
Other versions
EP1012260A1 (fr
Inventor
Steven M Ruben
Reinhard Ebner
Roxanne D Duan
Kimberly A Florence
Jing-Shan Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1012260A1 publication Critical patent/EP1012260A1/fr
Publication of EP1012260A4 publication Critical patent/EP1012260A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP98936854A 1997-07-16 1998-07-15 Interleukine-20 Withdrawn EP1012260A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5287097P 1997-07-16 1997-07-16
US52870P 1997-07-16
US6014097P 1997-09-26 1997-09-26
US60140P 1997-09-26
PCT/US1998/014609 WO1999003982A1 (fr) 1997-07-16 1998-07-15 Interleukine-20

Publications (2)

Publication Number Publication Date
EP1012260A1 EP1012260A1 (fr) 2000-06-28
EP1012260A4 true EP1012260A4 (fr) 2001-05-09

Family

ID=26731192

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98936854A Withdrawn EP1012260A4 (fr) 1997-07-16 1998-07-15 Interleukine-20

Country Status (5)

Country Link
EP (1) EP1012260A4 (fr)
JP (1) JP2001510035A (fr)
AU (1) AU8571198A (fr)
CA (1) CA2296762A1 (fr)
WO (1) WO1999003982A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6486301B1 (en) * 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
US6562578B1 (en) 1999-01-11 2003-05-13 Schering Corporation IL-17-like cytokine binding compounds and antibodies
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
EP3112468A1 (fr) * 1998-05-15 2017-01-04 Genentech, Inc. Polypeptides allogéniques il-17 et utilisations thérapeutiques
EP1865061A3 (fr) * 1998-05-15 2007-12-19 Genentech, Inc. Polypeptides allogéniques IL-17 et utilisations thérapeutiques
PT1076703E (pt) 1998-05-15 2007-10-10 Genentech Inc ''utilizações terapêuticas de polipéptido homólogos de il-17''
JP2003521239A (ja) * 1999-04-09 2003-07-15 キュラジェン コーポレイション 新規ヒトタンパク質およびそれらをコードするポリヌクレオチド
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
PT1897944E (pt) * 1999-12-23 2011-11-28 Genentech Inc Polipéptidos homólogos de il-17 e suas utilizações terapêuticas
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
ATE339450T1 (de) * 1999-12-23 2006-10-15 Zymogenetics Inc Verfahren zur behandlung von entzündungen
ATE407950T1 (de) * 1999-12-23 2008-09-15 Zymogenetics Inc Löslicher interleukin-20 rezeptor
JP2016047051A (ja) * 1999-12-23 2016-04-07 ジェネンテック， インコーポレイテッド Ｉｌ−１７相同的ポリペプチドとその治療上の用途
CA2401716A1 (fr) * 2000-02-29 2001-09-07 Zymogenetics, Inc. Procedes permettant de favoriser la production de myeline par les cellules de schwann
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE60123998T2 (de) 2000-08-08 2007-09-06 Zymogenetics, Inc., Seattle Lösliche zcyctor 11 cytokinrezeptoren
ATE460429T1 (de) 2000-09-15 2010-03-15 Zymogenetics Inc Polypeptide enthaltend extrazellulären domäne von il-20ra und/oderr il-20rb
EP1531843B1 (fr) * 2001-12-17 2011-08-24 ZymoGenetics, Inc. Methode de traitement du cancer du col de l'uterus
WO2003090779A1 (fr) * 2002-04-25 2003-11-06 Chugai Seiyaku Kabushiki Kaisha Remede contre le cancer du poumon
KR20110091598A (ko) 2003-03-24 2011-08-11 지모제넥틱스, 인코포레이티드 항-ｉｌ-22ｒａ 항체 및 결합 파트너 및 염증에 있어서의 사용 방법
JP4991307B2 (ja) 2003-11-21 2012-08-01 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法
UA96122C2 (ru) 2004-10-22 2011-10-10 Займодженетикс, Инк Антитело или его антигенсвязующий фрагмент, которое специфически связывается с il-22ra, и его применение
WO2007019453A2 (fr) * 2005-08-04 2007-02-15 Zymogenetics, Inc. Traitement de plaies au moyen de l'il-17b
JP2010509364A (ja) * 2006-11-08 2010-03-25 ザイモジェネティクス， インコーポレイテッド 創傷治癒における使用のためのｉｌ−１７ｂ
KR20150002874A (ko) 2008-05-05 2015-01-07 노비뮨 에스 에이 항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
CN102458437B (zh) 2009-05-05 2015-06-10 诺维莫尼公司 抗il-17f抗体及其使用方法
US8454956B2 (en) 2009-08-31 2013-06-04 National Cheng Kung University Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
BR112012021576A2 (pt) 2010-02-26 2016-10-25 Novo Nordisk As composições estáveis contendo anticorpo.
WO2011147921A1 (fr) 2010-05-28 2011-12-01 Novo Nordisk A/S Compositions stables multi-doses comprenant un anticorps et un agent conservateur
US9221904B2 (en) 2012-07-19 2015-12-29 National Cheng Kung University Treatment of osteoarthritis using IL-20 antagonists
US8603470B1 (en) 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US8852588B2 (en) 2012-08-07 2014-10-07 National Cheng Kung University Treating allergic airway disorders using anti-IL-20 receptor antibodies

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049310A1 (fr) * 1997-04-25 1998-11-05 Zymogenetics, Inc. Facteur 7 mammalien du type cytokine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562333B1 (en) * 1993-06-14 2003-05-13 Schering Corporation Purified mammalian CTLA-8 antigens and related reagents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049310A1 (fr) * 1997-04-25 1998-11-05 Zymogenetics, Inc. Facteur 7 mammalien du type cytokine

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EMBL; 16 September 1996 (1996-09-16), WUECHNER: "H. sapiens FGFR3 gene, intron 7", XP002161117 *
LI ET AL.: "Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family", PROC. NATL. ACAD. SCI. USA, vol. 97, no. 2, 18 January 2000 (2000-01-18), pages 773 - 778, XP002161115 *
See also references of WO9903982A1 *
SHI ET AL.: "A novel cytokine receptor-ligand pair: Identification, molecular characterization and in vivo immunomodulatory activty", J. BIOL. CHEM., vol. 275, no. 23, 23 June 2000 (2000-06-23), pages 19167 - 19176, XP002161114 *
YAO ET AL.: "Human IL-17: a novel cytokine derived from T cells", J. IMMUNOL., vol. 155, no. 12, 15 December 2000 (2000-12-15), pages 5483 - 5486, XP000602481 *

Also Published As

Publication number Publication date
EP1012260A1 (fr) 2000-06-28
JP2001510035A (ja) 2001-07-31
CA2296762A1 (fr) 1999-01-28
AU8571198A (en) 1999-02-10
WO1999003982A1 (fr) 1999-01-28

Similar Documents

Publication Publication Date Title
EP1012260A4 (fr) Interleukine-20
DE69810130D1 (en) Rotationspumpe mit tauchrotor
DE59803915D1 (en) Bandwaage
DE59806556D1 (en) Fmcw-sensor
DE19881579D2 (en) Kompressor mit überlastenkopplungseinrichtung
DE59805100D1 (en) Containerbrücke
DE59803341D1 (en) Handhobelmaschine
DE69727985D1 (en) Extravasationserkennungsvorrichtung
DE59811907D1 (en) Transponder-system
DE69801658D1 (en) Polyurethanhartschaumstoffe
DE59708342D1 (en) Basophilen-degranulationstest
DE69729893D1 (en) Druckbläter
DE69804606D1 (en) Cyclohexandiolderivate
DE69715258D1 (en) Präzisionshydraulikfutter
DE69805998D1 (en) Photowirksame cumarinderivate
DE69737400D1 (en) Substituierte naphthopyrane
DE69735266D1 (en) Substituierte naphthopyrane
CA82748S (en) Handleset
CA82745S (en) Handleset
CA82746S (en) Handleset
DE59809032D1 (en) Telephonsystem
CA82333S (en) Remorque
DE59811113D1 (en) Laryngoskop
CA79884S (en) Moniitor
CA80851S (en) Thermomter

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): FR

A4 Supplementary search report drawn up and despatched

Effective date: 20010323

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): FR

17Q First examination report despatched

Effective date: 20030918

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050127